PMTCT could cause drug resistance in positive infants
Drug regimens used in the prevention of mother-to-child transmission (PMTCT) of HIV are effective, but infants should be monitored for drug resistance, a new study has revealed.
The study in Kisumu, western Kenya, found that the triple combination of antiretroviral (ARV) drugs given to HIV-infected mothers to prevent transmission of the virus to their infants was effective and feasible, but there were cases of possible drug resistance in HIV-positive infants. Read on.
